Menu
Not yet recruiting NCT07172087

Construction and Empirical Research of the Applicable Baduanjin Protocol for Patients With Colorectal Cancer Enterostomy

No phase Interventional Colorectal Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Baduanjin for patients with enterostomy.
Who it may be relevant to
Registry conditions: Colorectal Cancer. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The goal of this clinical trial is to understand the application effect of the applicable version of Baduanjin protocol in patients with enterostomy and verify the safety and efficacy of this protocol. The main questions it aims to answer are: Can the applicable version of Baduanjin protocol be safely and effectively applied to patients with enterostomy? Researchers will compare the applicable version of the Baduanjin exercise with the walking exercise to see if the applicable version of the Baduanjin regimen is safe and effective for patients with enterostomy. Participants will: Apply the version of Baduanjin exercise or walking exercise five times a week for 12 weeks Patients signed in to the researchers of the project through forms such as exercise record sheets, videos uploaded on wechat, and records made through the keep app.

Interventions

  • Other Baduanjin for patients with enterostomy
    Modified Baduanjin exercise: a standardized, low-to-moderate intensity qigong regimen consisting of eight sequential movements combined with diaphragmatic breathing. The program excludes any additional resistance or aerobic training and is compared with routine walking exercise only.

Primary outcome measures

  • Exercise Benefits and Barriers Scale（EBBS） [Time frame: Baseline (Before enterostomy in patients with colorectal cancer), 4 weeks and 16 weeks after the operation]
  • Pittsburgh Sleep Quality Index（PSQI） [Time frame: Baseline (Before enterostomy in patients with colorectal cancer) and at 4, 8, 12 and 16 weeks after the operation]
  • Chinese Ostomy Adjustment Inventory（C-OAI） [Time frame: 4 weeks, 8 weeks, 12 weeks and 16 weeks after enterostomy]
  • Cancer Fatigue Scale（CFS) [Time frame: Baseline (Before enterostomy in patients with colorectal cancer) and at 4, 8, 12 and 16 weeks after the operation]
  • Stoma Quality of Life Scale（Stoma-QOL） [Time frame: 4 weeks, 8 weeks, 12 weeks and 16 weeks after enterostomy]

Eligibility criteria

Inclusion criteria

  • The disease diagnosis is colorectal cancer
  • At present, enterostomy is used for excretion, and the enterostomy time is more than one month
  • Age ≥ 18 years old
  • Have normal cognitive and expression abilities
  • Voluntarily participate in this study and have signed the informed consent form.

Exclusion criteria

  • In the past three months, I have participated in any intervention research or traditional Chinese medical exercise training programs (such as Tai Chi, Baduanjin, other Qigong exercises, etc.)
  • Patients with severe functional disorders of the heart, lungs, liver, kidneys and other organs
  • Mental abnormalities and language expression disorders
  • Patients with limb dysfunction who are unable to cooperate in completing the Baduanjin training
  • Various drainage tubes, PICC catheters, etc. were retained -

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

China · 1 center
  • Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan — Chengdu

Identifiers

NCT: NCT07172087 · KY-2025-248-02

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗